Qun Liu Selected Research

Secondary Prevention

8/2011	Effect of socioeconomic status on secondary prevention of stroke.
5/2009	[Prevalence, awareness, and treatment of hypercholesterolemia among inpatients with acute coronary syndrome in China].
4/2009	The association between socioeconomic status of high-risk patients with coronary heart disease and the treatment rates of evidence-based medicine for coronary heart disease secondary prevention in China: Results from the Bridging the Gap on CHD Secondary Prevention in China (BRIG) Project.
6/2008	[Study on the prevalence of diabetes mellitus among acute coronary syndrome inpatients in a multiprovincial study in China].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qun Liu Research Topics

Disease

44	Neoplasms (Cancer) 03/2024 - 05/2003
25	Infections 01/2023 - 11/2004
17	Breast Neoplasms (Breast Cancer) 12/2023 - 11/2009
14	Neoplasm Metastasis (Metastasis) 12/2022 - 09/2009
9	Inflammation (Inflammations) 05/2024 - 03/2015
9	Burns 12/2015 - 06/2004
7	Lung Neoplasms (Lung Cancer) 03/2024 - 05/2020
7	Hypoxia (Hypoxemia) 01/2023 - 06/2009
7	Ovarian Neoplasms (Ovarian Cancer) 12/2022 - 11/2008
7	Non-alcoholic Fatty Liver Disease 01/2022 - 02/2018
6	Alzheimer Disease (Alzheimer's Disease) 12/2022 - 11/2012
6	Mitochondrial Diseases (Mitochondrial Disease) 08/2022 - 01/2015
6	Body Weight (Weight, Body) 08/2020 - 06/2012
6	Myocardial Ischemia (Ischemic Heart Diseases) 04/2020 - 06/2009
6	Glioma (Gliomas) 01/2020 - 05/2012
5	Toxoplasmosis 11/2023 - 03/2012
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2019
5	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2012
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 05/2007
4	Fibrosis (Cirrhosis) 10/2023 - 01/2020
4	Coccidiosis 12/2022 - 11/2004
4	Brain Injuries (Brain Injury) 07/2022 - 11/2012
4	Hypertension (High Blood Pressure) 01/2022 - 03/2009
4	Heart Failure 01/2022 - 12/2017
4	Colonic Neoplasms (Colon Cancer) 01/2020 - 01/2015
4	Ischemia 01/2019 - 11/2012
4	Wounds and Injuries (Trauma) 08/2016 - 02/2006
3	Prostatic Neoplasms (Prostate Cancer) 05/2024 - 11/2013
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2024 - 08/2010
3	Necrosis 10/2022 - 01/2015
3	Hyperglycemia 01/2022 - 10/2018
3	Obesity 01/2022 - 11/2012
3	Coronary Disease (Coronary Heart Disease) 01/2022 - 04/2009
3	Myocardial Infarction 01/2021 - 12/2012
3	Carcinogenesis 05/2020 - 01/2015
3	Neuralgia (Stump Neuralgia) 01/2020 - 05/2003
3	Type 2 Diabetes Mellitus (MODY) 01/2017 - 01/2015
3	Carcinoma (Carcinomatosis) 05/2016 - 07/2004
3	Leukemia 02/2016 - 11/2013
3	Stroke (Strokes) 01/2016 - 04/2008
3	Myasthenia Gravis 01/2015 - 08/2012
3	Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial) 03/2007 - 03/2004
2	Hepatitis B 05/2024 - 05/2012
2	Disease Progression 03/2024 - 01/2015
2	Hemorrhage 02/2024 - 11/2018
2	Triple Negative Breast Neoplasms 12/2023 - 01/2018
2	COVID-19 12/2023 - 01/2021

Drug/Important Bio-Agent (IBA)

40	Proteins (Proteins, Gene)FDA Link 06/2024 - 02/2007
9	AntigensIBA 11/2023 - 10/2008
9	VaccinesIBA 12/2022 - 11/2004
9	Messenger RNA (mRNA)IBA 10/2022 - 11/2012
8	Glucose (Dextrose)FDA LinkGeneric 02/2023 - 02/2007
7	Long Noncoding RNAIBA 01/2022 - 05/2019
6	Estrogen ReceptorsIBA 12/2023 - 11/2009
6	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2015
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 05/2003
5	AntibodiesIBA 05/2024 - 10/2012
5	Small Interfering RNA (siRNA)IBA 01/2023 - 05/2012
5	LipidsIBA 01/2022 - 11/2012
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2009
4	Indicators and Reagents (Reagents)IBA 01/2022 - 11/2009
4	shogaolIBA 01/2015 - 01/2012
3	CollagenIBA 01/2023 - 01/2020
3	Oxygen (Dioxygen)IBA 01/2023 - 01/2018
3	AluminumIBA 10/2022 - 01/2021
3	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2022 - 10/2009
3	Adenosine Triphosphate (ATP)IBA 08/2022 - 01/2015
3	EnzymesIBA 01/2022 - 01/2016
3	CalciumIBA 01/2022 - 01/2019
3	AconitineIBA 01/2022 - 07/2021
3	Neuroprotective AgentsIBA 01/2022 - 01/2014
3	Glucagon (Glukagon)FDA Link 01/2022 - 01/2017
3	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 09/2009
3	DNA (Deoxyribonucleic Acid)IBA 10/2018 - 06/2012
3	Succinic Acid (Succinate)IBA 01/2018 - 01/2017
3	GinsenosidesIBA 01/2018 - 02/2015
3	ParaffinIBA 01/2018 - 09/2009
3	CaspasesIBA 01/2017 - 01/2012
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2015 - 11/2012
3	HDL CholesterolIBA 02/2014 - 05/2007
3	Caspase 3 (Caspase-3)IBA 11/2013 - 01/2012
3	ApolipoproteinsIBA 03/2007 - 03/2004
2	AutoantibodiesIBA 05/2024 - 01/2015
2	Retinaldehyde (Retinal)IBA 02/2024 - 01/2023
2	Transcription Factors (Transcription Factor)IBA 12/2023 - 11/2019
2	Protein Isoforms (Isoforms)IBA 12/2023 - 01/2021
2	HydrogelsIBA 09/2023 - 04/2008
2	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2023 - 03/2015
2	Circular RNAIBA 02/2023 - 06/2021
2	Interleukin-1 (Interleukin 1)IBA 02/2023 - 06/2018

Therapy/Procedure

20	Therapeutics 02/2024 - 09/2009
11	Electroacupuncture 10/2023 - 09/2018
9	Drug Therapy (Chemotherapy) 12/2023 - 05/2003
5	Immunotherapy 12/2022 - 08/2010
4	Transplantation 01/2022 - 04/2012
4	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 05/2012
4	Secondary Prevention 08/2011 - 06/2008
3	Radiotherapy 12/2023 - 11/2019
3	Oral Administration 01/2017 - 05/2003
3	Microspheres (Microsphere) 06/2015 - 10/2009